Symphorna Limited

	Page
Balance Sheet	1—2
Notes to the Financial Statements	3—6

1. General Information

Symphorna Limited is a private company, limited by shares, incorporated in England & Wales, registered number 16544054 . The registered office is 25 Bioinnovation Centre, Cambridge Science Park, Milton, Cambridge, England, CB4 0FW.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

2.2. Going Concern Disclosure

The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going concern. Therefore the financial statements have been prepared on a going concern basis which assumes the Company will continue in operational existence for the foreseeable future.

The Company is involved in research and development activities and is working towards achieving a sustainable revenue generating activity. The directors have considered the basis of the financial statements and are satisfied that a combination of business growth and further investment commitments will enable the Company to meet its liabilities as they fall due.

2.3. Intangible Fixed Assets and Amortisation - Other Intangible

Other intangible assets are Patents. These are amortised to the profit and loss account over their estimated economic life of 7 years.

2.4. Research and Development

Development assets are related to development platforms for medicines. These are amortised to the profit and loss account over their estimated economic life of 4 years.

2.5. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Plant & Machinery	4 years straight line
Computer Equipment	3 years straight line

2.6. Cash and Cash Equivalents

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks, other short-term highly liquid investments that mature in no more than three months from the date of acquisition and are readily convertible to a known amount of cash with insignificant risk of change in value, and bank overdrafts.

2.7. Financial Instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include debtors and bank balances, are measured at transaction price including transaction costs.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

...CONTINUED

Page 3

Page 4

Symphorna Limited

Notes to the Financial Statements (continued)

For The Year Ended 30 June 2026

2.7. Financial Instruments - continued

Basic financial liabilities

Basic financial liabilities, including creditors, are recognised at transaction price including transaction costs.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities.

2.8. Foreign Currencies

Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the profit / loss before taxation.

2.9. Taxation

Tax is recognised in profit or loss except that a charge is attributable to an item of income and expense recognised as other comphrehensive income or to an item recognised directly in equity is also recognised in other comphrehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the company operates and generates income.

2.10. Pensions

The company operates a defined pension contribution scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.

2.11. Research and Development

In the research phase of an internal project, it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight-line basis over their useful economic lives.

If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.

3. Average Number of Employees

Average number of employees, including directors, during the year was: 4

4. Intangible Assets

	Other - Patents	Development Costs	Total
	£	£	£
Cost
As at 26 June 2025	-	-	-
Additions	38,098	940,929	979,027

As at 30 June 2026	38,098	940,929	979,027

Amortisation
As at 26 June 2025	-	-	-
Provided during the period	3,086	70,892	73,978

As at 30 June 2026	3,086	70,892	73,978

Net Book Value
As at 30 June 2026	35,012	870,037	905,049

As at 26 June 2025	-	-	-

Page 4

Page 5

Symphorna Limited

Notes to the Financial Statements (continued)

For The Year Ended 30 June 2026

5. Tangible Assets

	Plant & Machinery	Computer Equipment	Total
	£	£	£
Cost
As at 26 June 2025	-	-	-
Additions	74,270	1,357	75,627

As at 30 June 2026	74,270	1,357	75,627

Depreciation
As at 26 June 2025	-	-	-
Provided during the period	20,157	129	20,286

As at 30 June 2026	20,157	129	20,286

Net Book Value
As at 30 June 2026	54,113	1,228	55,341

As at 26 June 2025	-	-	-

6. Debtors

	2026
	£
Due within one year
Prepayments and accrued income	47,074
Other debtors	159
Corporation tax recoverable assets	122,149
VAT	57,268

	226,650

7. Creditors: Amounts Falling Due Within One Year

	2026
	£
Trade creditors	148,313
Other taxes and social security	29,129
Other creditors	2,566
Accruals and deferred income	11,750
Amounts owed to related parties	2,346

	194,104

Page 5

Page 6

Symphorna Limited

Notes to the Financial Statements (continued)

For The Year Ended 30 June 2026

8. Share Capital

	2026
Allotted, called up and fully paid	£
5,718,461 Ordinary A shares of £ 0.000001 each	6
1,710,513 Ordinary B shares of £ 0.000001 each	2

	8


Shares issued during the period:	£
5,718,461 Ordinary A shares of £ 0.000001 each	6
1,710,513 Ordinary B shares of £ 0.000001 each	2

	8

On incorporation, 26 June 2025, 5,718,461 Ordinary shares of £0.000001 each were allotted and fully paid at a pice of £0.000001 per share.

On 6 March 2026 the Ordinary shares were reclassified as A Ordinary shares of the same value.

On 13 March 2026, 534,055 B Ordinary shares of £0.000001 each were allotted and fully paid at a price of £2.607 per share.

On 20 March 2026, 998,163 B Ordinary shares of £0.000001 each were allotted and fully paid at a price of £1.413 per share.

On 24 March 2026, 1,415 B Ordinary shares of £0.000001 each were allotted and fully paid at a price of £1.413 per share.

On 25 March 2026, 176,880 B Ordinary shares of £0.000001 each were allotted and fully paid at a price of £1.413 per share.

9. Other Commitments

The total of future minimum lease payments under non-cancellable operating leases are as following:

	2026
	£
Not later than one year	150,899
Later than one year and not later than five years	113,174

	264,073

Page 6

		2026
	Notes	£	£
FIXED ASSETS
Intangible Assets	4		905,049
Tangible Assets	5		55,341

			960,390
CURRENT ASSETS
Debtors	6	226,650
Cash at bank and in hand		1,288,107

		1,514,757
Creditors: Amounts Falling Due Within One Year	7	(194,104 )

NET CURRENT ASSETS (LIABILITIES)			1,320,653

TOTAL ASSETS LESS CURRENT LIABILITIES			2,281,043

NET ASSETS			2,281,043

CAPITAL AND RESERVES
Called up share capital	8		8
Share premium account			3,055,028
Profit and Loss Account			(773,993 )

SHAREHOLDERS' FUNDS			2,281,043